Prophylactic eculizumab for kidney transplantation in a child with atypical hemolytic uremic syndrome due to complement factor H mutation.
about
Critical appraisal of eculizumab for atypical hemolytic uremic syndromeOutcomes of patients with atypical haemolytic uraemic syndrome with native and transplanted kidneys treated with eculizumab: a pooled post hoc analysis.Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea.Incomplete inhibition by eculizumab: mechanistic evidence for residual C5 activity during strong complement activation.
P2860
Prophylactic eculizumab for kidney transplantation in a child with atypical hemolytic uremic syndrome due to complement factor H mutation.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Prophylactic eculizumab for ki ...... complement factor H mutation.
@ast
Prophylactic eculizumab for ki ...... complement factor H mutation.
@en
type
label
Prophylactic eculizumab for ki ...... complement factor H mutation.
@ast
Prophylactic eculizumab for ki ...... complement factor H mutation.
@en
prefLabel
Prophylactic eculizumab for ki ...... complement factor H mutation.
@ast
Prophylactic eculizumab for ki ...... complement factor H mutation.
@en
P2093
P2860
P356
P1476
Prophylactic eculizumab for ki ...... complement factor H mutation.
@en
P2093
Barrett Crowther
Chatchawin Assanasen
Daniel Ranch
Mazen Arar
P2860
P304
P356
10.1111/PETR.12290
P577
2014-06-14T00:00:00Z